Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Pediatric Radiation Oncology

E-BookPDF1 - PDF WatermarkE-Book
462 Seiten
Englisch
Springer Nature Switzerlanderschienen am01.03.20181st ed. 2018
This book presents the most up-to-date and innovative information on the targeting and treatment of a wide range of childhood cancers by means of radiation therapy. Written by global experts in pediatric radiation oncology, it documents in detail the treatment regimens appropriate to each disease, highlighting the recent advances that promise to improve rates of survival and cure. The use of image-guided and intensity-modulated radiation therapy is clearly described, and careful attention is also devoted to the roles of proton therapy, stereotactic radiosurgery, stereotactic fractionated radiosurgery, and modulated arc radiotherapy. Separate chapters address localization and verification procedures and anesthesia; pediatric radiation oncology in the palliative care setting; and aspects that are especially relevant in low- and medium-income countries. Beyond clinical radiation oncology, relevant information is provided on radiation physics. The book concludes by examining future directions in the field.



Dr. Thomas E. Merchant is Chair of Radiation Oncology at St. Jude Children's Research Hospital in Memphis, Tennessee, Baddia J. Rashid Endowed Chair in Radiation Oncology, and former chairman of the Radiation Oncology Discipline, Children's Oncology Group (COG).

Dr. Merchant is board certified in Radiation Oncology and received his medical degree from the Chicago College of Osteopathic Medicine, Chicago, Illinois and Ph.D. in experimental pathology from the University of Utrecht, The Netherlands.
As Chair of Radiation Oncology, Dr. Merchant oversees a department that includes nearly 70 faculty and staff dedicated to pediatric radiation oncology. The focus of his practice and research includes the following diseases: medulloblastoma, ependymoma, craniopharyngioma, and low-grade glioma. His special interests include brain tumors in young children, side effects of radiation therapy, re-irradiation, and proton therapy. He led the development of the St. Jude Red Frog Events Proton Therapy Center. The world's first proton therapy center dedicated solely to the treatment of pediatric cancer patients.


Dr. Rolf-Dieter Kortmann is a Professor in Medicine and Head of Department of Radiation Therapy, University of Leipzig, Germany.

Dr. Kortmann was trained in radiology and radiooncology at the Department of Radiology and the Department of Radiooncology in Stuttgart, Essen and Tuebingen, Germany. The scientific expertise comprises quality control in radiation oncology with special emphasis on geometric precision of different radiotherapy technologies including craniospinal irradiation.

After qualification for radiation oncology in 1992, scientific research focused mainly on childhood brain tumours finally leading to the establishment of the German Study and Reference Centre for Paediatric Radiation Oncology in Childhood Brain Tumours. With the introduction of prospective brain tumour trials in Germany in the early 90s
prospective quality control programmes for radiotherapy were introduced on a nationwide level.


The activities also included prospective trials of SIOP (International Society for Paediatric Oncology) for medulloblastoma and intracranial germ cell tumours.

Since 2004 educational programmes have been created for the now independent countries of the former Soviet Union in collaboration with the International Atomic Energy Agency (IAEA) and the European Society of Therapeutic Radiation Oncology (ESTRO). Currently, ESTRO-PROS Teaching Courses are organized addressing radiation oncologists worldwide.

Special Interest: Paediatric Radiooncology, CNS Tumours, Quality Assurance
mehr
Verfügbare Formate
BuchGebunden
EUR192,59
E-BookPDF1 - PDF WatermarkE-Book
EUR69,54

Produkt

KlappentextThis book presents the most up-to-date and innovative information on the targeting and treatment of a wide range of childhood cancers by means of radiation therapy. Written by global experts in pediatric radiation oncology, it documents in detail the treatment regimens appropriate to each disease, highlighting the recent advances that promise to improve rates of survival and cure. The use of image-guided and intensity-modulated radiation therapy is clearly described, and careful attention is also devoted to the roles of proton therapy, stereotactic radiosurgery, stereotactic fractionated radiosurgery, and modulated arc radiotherapy. Separate chapters address localization and verification procedures and anesthesia; pediatric radiation oncology in the palliative care setting; and aspects that are especially relevant in low- and medium-income countries. Beyond clinical radiation oncology, relevant information is provided on radiation physics. The book concludes by examining future directions in the field.



Dr. Thomas E. Merchant is Chair of Radiation Oncology at St. Jude Children's Research Hospital in Memphis, Tennessee, Baddia J. Rashid Endowed Chair in Radiation Oncology, and former chairman of the Radiation Oncology Discipline, Children's Oncology Group (COG).

Dr. Merchant is board certified in Radiation Oncology and received his medical degree from the Chicago College of Osteopathic Medicine, Chicago, Illinois and Ph.D. in experimental pathology from the University of Utrecht, The Netherlands.
As Chair of Radiation Oncology, Dr. Merchant oversees a department that includes nearly 70 faculty and staff dedicated to pediatric radiation oncology. The focus of his practice and research includes the following diseases: medulloblastoma, ependymoma, craniopharyngioma, and low-grade glioma. His special interests include brain tumors in young children, side effects of radiation therapy, re-irradiation, and proton therapy. He led the development of the St. Jude Red Frog Events Proton Therapy Center. The world's first proton therapy center dedicated solely to the treatment of pediatric cancer patients.


Dr. Rolf-Dieter Kortmann is a Professor in Medicine and Head of Department of Radiation Therapy, University of Leipzig, Germany.

Dr. Kortmann was trained in radiology and radiooncology at the Department of Radiology and the Department of Radiooncology in Stuttgart, Essen and Tuebingen, Germany. The scientific expertise comprises quality control in radiation oncology with special emphasis on geometric precision of different radiotherapy technologies including craniospinal irradiation.

After qualification for radiation oncology in 1992, scientific research focused mainly on childhood brain tumours finally leading to the establishment of the German Study and Reference Centre for Paediatric Radiation Oncology in Childhood Brain Tumours. With the introduction of prospective brain tumour trials in Germany in the early 90s
prospective quality control programmes for radiotherapy were introduced on a nationwide level.


The activities also included prospective trials of SIOP (International Society for Paediatric Oncology) for medulloblastoma and intracranial germ cell tumours.

Since 2004 educational programmes have been created for the now independent countries of the former Soviet Union in collaboration with the International Atomic Energy Agency (IAEA) and the European Society of Therapeutic Radiation Oncology (ESTRO). Currently, ESTRO-PROS Teaching Courses are organized addressing radiation oncologists worldwide.

Special Interest: Paediatric Radiooncology, CNS Tumours, Quality Assurance
Details
Weitere ISBN/GTIN9783319435459
ProduktartE-Book
EinbandartE-Book
FormatPDF
Format Hinweis1 - PDF Watermark
FormatE107
Erscheinungsjahr2018
Erscheinungsdatum01.03.2018
Auflage1st ed. 2018
Seiten462 Seiten
SpracheEnglisch
Dateigrösse20952 Kbytes
IllustrationenVIII, 462 p.
Artikel-Nr.3379915
Rubriken
Genre9200

Inhalt/Kritik

Inhaltsverzeichnis
Ewing Sarcoma and DSRCT.- Rhabdomyosarcoma.- Soft-tissue Sarcoma and Osteosarcoma.- Neuroblastoma.- Wilms Tumor.- Retinoblastoma and Rare Solid Tumors.- Glioma.- Medulloblastoma and SPNET.- ATRT.- CNS Germ Cell Tumors.- Ependymoma.- Craniopharyngioma.- Stem Cell Transplantation.- Leukemia/ Lymphoma.- Hodgkin Lymphoma.- Radiation Physics. Proton Therapy.- Localization, Verification, and Anesthesia.- Palliative Care.- Low and Medium Income Countries.- Future Directions.mehr

Autor

Dr. Thomas E. Merchant is Chair of Radiation Oncology at St. Jude Children's Research Hospital in Memphis, Tennessee, Baddia J. Rashid Endowed Chair in Radiation Oncology, and former chairman of the Radiation Oncology Discipline, Children's Oncology Group (COG).

Dr. Merchant is board certified in Radiation Oncology and received his medical degree from the Chicago College of Osteopathic Medicine, Chicago, Illinois and Ph.D. in experimental pathology from the University of Utrecht, The Netherlands.
As Chair of Radiation Oncology, Dr. Merchant oversees a department that includes nearly 70 faculty and staff dedicated to pediatric radiation oncology. The focus of his practice and research includes the following diseases: medulloblastoma, ependymoma, craniopharyngioma, and low-grade glioma. His special interests include brain tumors in young children, side effects of radiation therapy, re-irradiation, and proton therapy. He led the development of the St. Jude Red Frog Events Proton Therapy Center. The world's first proton therapy center dedicated solely to the treatment of pediatric cancer patients.


Dr. Rolf-Dieter Kortmann is a Professor in Medicine and Head of Department of Radiation Therapy, University of Leipzig, Germany.

Dr. Kortmann was trained in radiology and radiooncology at the Department of Radiology and the Department of Radiooncology in Stuttgart, Essen and Tuebingen, Germany. The scientific expertise comprises quality control in radiation oncology with special emphasis on geometric precision of different radiotherapy technologies including craniospinal irradiation.

After qualification for radiation oncology in 1992, scientific research focused mainly on childhood brain tumours finally leading to the establishment of the German Study and Reference Centre for Paediatric Radiation Oncology in Childhood Brain Tumours. With the introduction of prospective brain tumour trials in Germany in the early 90s
prospective quality control programmes for radiotherapy were introduced on a nationwide level.


The activities also included prospective trials of SIOP (International Society for Paediatric Oncology) for medulloblastoma and intracranial germ cell tumours.

Since 2004 educational programmes have been created for the now independent countries of the former Soviet Union in collaboration with the International Atomic Energy Agency (IAEA) and the European Society of Therapeutic Radiation Oncology (ESTRO). Currently, ESTRO-PROS Teaching Courses are organized addressing radiation oncologists worldwide.

Special Interest: Paediatric Radiooncology, CNS Tumours, Quality Assurance
Weitere Artikel von
Merchant, Thomas E.
Hrsg.
Weitere Artikel von
Kortmann, Rolf-Dieter
Hrsg.